|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment Securities | ||||||||||||||||||||
| Trade accounts receivable, less allowance for credit losses of $3,000 | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Inventories: | ||||||||||||||||||||
| Raw materials | ||||||||||||||||||||
| Work-in-process | ||||||||||||||||||||
| Costs related to contracts in process | ||||||||||||||||||||
| Total inventories | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Net deferred tax assets | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Net deferred tax assets | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses: | ||||||||||||||||||||
| Salaries and wages | ||||||||||||||||||||
| Vacation | ||||||||||||||||||||
| ESOP payable | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Payroll and other taxes withheld | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, par value $.33-1/3 per share Authorized 10,000,000 shares; Issued 3,129,874 shares as of June 30, 2026 and 2025. Outstanding 3,007,672 and 2,896,368 shares as of June 30, 2026 and 2025, respectively (Includes 168,636 and 189,817 Unearned ESOP Shares, respectively) | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Accumulated other comprehensive gain | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Less: Unearned ESOP shares | ||||||||||||||||||||
| Cost of 122,202 and 233,506 shares of common stock in treasury as of June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
